Characterization of KPC-encoding plasmids from two endemic settings, Greece and Italy-Reference-Cited by-同舟云学术

Characterization of KPC-encoding plasmids from two endemic settings, Greece and Italy

Published:2016-06-21 Issue:10 Volume:71 Page:2824-2830
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:J. Antimicrob. Chemother.

Author:

Papagiannitsis Costas C.,Di Pilato Vincenzo,Giani Tommaso,Giakkoupi Panagiota,Riccobono Eleonora,Landini Giulia,Miriagou Vivi,Vatopoulos Alkiviadis C.,Rossolini Gian Maria

Funder

European Community

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/71/10/2824/17430186/dkw227.pdf

Reference51 articles.

1. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study

2. Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance

3. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015

4. An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10)

5. KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperendemic clone;Giakkoupi;Euro Surveill,2009

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic insights into the expansion of carbapenem-resistant Klebsiella pneumoniae within Portuguese hospitals;Journal of Hospital Infection;2024-06

2. A novel KPC-166 in ceftazidime/avibactam resistant ST307 Klebsiella pneumoniae causing an outbreak in intensive care COVID Unit, Italy;Journal of Microbiology, Immunology and Infection;2024-06

3. Carbapenem-resistant Klebsiella pneumoniae : the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge;Expert Review of Anti-infective Therapy;2024-01-30

4. Functional features of KPC-109, a novel 270-loop KPC-3 mutant mediating resistance to avibactam-based β-lactamase inhibitor combinations and cefiderocol;International Journal of Antimicrobial Agents;2024-01

5. Citrobacter freundii resistant to novel β-lactamase inhibitor combinations and cefiderocol, co-producing class A, B and D carbapenemases encoded by transferable plasmids;Journal of Antimicrobial Chemotherapy;2023-05-19